309 related articles for article (PubMed ID: 11590438)
1. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle.
Perreault M; Marette A
Nat Med; 2001 Oct; 7(10):1138-43. PubMed ID: 11590438
[TBL] [Abstract][Full Text] [Related]
2. Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice.
Carvalho-Filho MA; Ueno M; Carvalheira JB; Velloso LA; Saad MJ
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E476-82. PubMed ID: 16638822
[TBL] [Abstract][Full Text] [Related]
3. Lack of inducible nitric oxide synthase does not prevent aging-associated insulin resistance.
Cha HN; Kim YW; Kim JY; Kim YD; Song IH; Min KN; Park SY
Exp Gerontol; 2010 Sep; 45(9):711-8. PubMed ID: 20493940
[TBL] [Abstract][Full Text] [Related]
4. Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance.
Zhao B; Wall RJ; Yang J
Biochem Biophys Res Commun; 2005 Nov; 337(1):248-55. PubMed ID: 16182246
[TBL] [Abstract][Full Text] [Related]
5. Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity.
Samane S; Christon R; Dombrowski L; Turcotte S; Charrouf Z; Lavigne C; Levy E; Bachelard H; Amarouch H; Marette A; Haddad PS
Metabolism; 2009 Jul; 58(7):909-19. PubMed ID: 19394055
[TBL] [Abstract][Full Text] [Related]
6. Peroxynitrite mediates muscle insulin resistance in mice via nitration of IRbeta/IRS-1 and Akt.
Zhou J; Huang K
Toxicol Appl Pharmacol; 2009 Nov; 241(1):101-10. PubMed ID: 19682478
[TBL] [Abstract][Full Text] [Related]
7. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice.
Dray C; Knauf C; Daviaud D; Waget A; Boucher J; Buléon M; Cani PD; Attané C; Guigné C; Carpéné C; Burcelin R; Castan-Laurell I; Valet P
Cell Metab; 2008 Nov; 8(5):437-45. PubMed ID: 19046574
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide bioavailability and not production is first altered during the onset of insulin resistance in sucrose-fed rats.
Blouet C; Mariotti F; Mathe V; Tome D; Huneau JF
Exp Biol Med (Maywood); 2007 Dec; 232(11):1458-64. PubMed ID: 18040070
[TBL] [Abstract][Full Text] [Related]
9. ATP-sensitive K+ channel-mediated glucose uptake is independent of IRS-1/phosphatidylinositol 3-kinase signaling.
Minami K; Morita M; Saraya A; Yano H; Terauchi Y; Miki T; Kuriyama T; Kadowaki T; Seino S
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1289-96. PubMed ID: 12933351
[TBL] [Abstract][Full Text] [Related]
10. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene.
Fenyk-Melody JE; Garrison AE; Brunnert SR; Weidner JR; Shen F; Shelton BA; Mudgett JS
J Immunol; 1998 Mar; 160(6):2940-6. PubMed ID: 9510198
[TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance.
Sugita H; Kaneki M; Tokunaga E; Sugita M; Koike C; Yasuhara S; Tompkins RG; Martyn JA
Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E386-94. PubMed ID: 11788371
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of the nitric oxide synthase 2 gene protects against ischaemia/reperfusion injury to skeletal muscle.
Barker JE; Knight KR; Romeo R; Hurley JV; Morrison WA; Stewart AG
J Pathol; 2001 May; 194(1):109-15. PubMed ID: 11329149
[TBL] [Abstract][Full Text] [Related]
13. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes.
Finck BN; Bernal-Mizrachi C; Han DH; Coleman T; Sambandam N; LaRiviere LL; Holloszy JO; Semenkovich CF; Kelly DP
Cell Metab; 2005 Feb; 1(2):133-44. PubMed ID: 16054054
[TBL] [Abstract][Full Text] [Related]
14. Inducible nitric oxide synthase deficiency ameliorates skeletal muscle insulin resistance but does not alter unexpected lower blood glucose levels after burn injury in C57BL/6 mice.
Sugita M; Sugita H; Kim M; Mao J; Yasuda Y; Habiro M; Shinozaki S; Yasuhara S; Shimizu N; Martyn JA; Kaneki M
Metabolism; 2012 Jan; 61(1):127-36. PubMed ID: 21816442
[TBL] [Abstract][Full Text] [Related]
15. Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase.
Li G; Labruto F; Sirsjö A; Chen F; Vaage J; Valen G
Eur J Cardiothorac Surg; 2004 Nov; 26(5):968-73. PubMed ID: 15519191
[TBL] [Abstract][Full Text] [Related]
16. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
Dokken BB; Henriksen EJ
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E207-13. PubMed ID: 16478771
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins.
Guler R; Olleros ML; Vesin D; Parapanov R; Vesin C; Kantengwa S; Rubbia-Brandt L; Mensi N; Angelillo-Scherrer A; Martinez-Soria E; Tacchini-Cottier F; Garcia I
J Hepatol; 2004 Nov; 41(5):773-81. PubMed ID: 15519650
[TBL] [Abstract][Full Text] [Related]
18. Aspirin attenuates insulin resistance in muscle of diet-induced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRbeta/IRS-1 and Akt.
Carvalho-Filho MA; Ropelle ER; Pauli RJ; Cintra DE; Tsukumo DM; Silveira LR; Curi R; Carvalheira JB; Velloso LA; Saad MJ
Diabetologia; 2009 Nov; 52(11):2425-34. PubMed ID: 19730809
[TBL] [Abstract][Full Text] [Related]
19. Chronic diabetic nephropathy: role of inducible nitric oxide synthase.
Trachtman H; Futterweit S; Pine E; Mann J; Valderrama E
Pediatr Nephrol; 2002 Jan; 17(1):20-9. PubMed ID: 11793130
[TBL] [Abstract][Full Text] [Related]
20. Ascorbate protects against impaired arteriolar constriction in sepsis by inhibiting inducible nitric oxide synthase expression.
Wu F; Wilson JX; Tyml K
Free Radic Biol Med; 2004 Oct; 37(8):1282-9. PubMed ID: 15451067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
